1592 related articles for article (PubMed ID: 17572998)
1. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
2. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
5. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
6. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD.
Chen Y; Chen P; Hanaoka M; Droma Y; Kubo K
Respirology; 2008 Nov; 13(7):1014-21. PubMed ID: 18699805
[TBL] [Abstract][Full Text] [Related]
7. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
Kong YJ; Sun WX; Zhang YM; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of inflammatory factors in sputum induced early after lung volume reduction surgery.
Miao JB; Hou SC; Li H; Hu B; Wang TY
Chin Med J (Engl); 2008 Sep; 121(18):1796-9. PubMed ID: 19080360
[TBL] [Abstract][Full Text] [Related]
9. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
11. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
12. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
13. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
14. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G
Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290
[TBL] [Abstract][Full Text] [Related]
15. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].
Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282
[TBL] [Abstract][Full Text] [Related]
16. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].
Cheng Z; Kang Y; Wu QG; Dai LL; Song YN; Xia J; Si JM; Chen CY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):2981-4. PubMed ID: 22333024
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of the airway inflammation and the relationship to interleukin-17 in severe asthma].
Zhou QT; Sun YC; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):630-4. PubMed ID: 16207434
[TBL] [Abstract][Full Text] [Related]
18. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
Tanaka H; Miyazaki N; Oashi K; Tanaka S; Ohmichi M; Abe S
J Allergy Clin Immunol; 2000 May; 105(5):900-5. PubMed ID: 10808169
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
20. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.
Kwiatkowska S; Noweta K; Zieba M; Nowak D; Bialasiewicz P
Respiration; 2012; 84(3):231-41. PubMed ID: 22832426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
